STARTSEITE
Impressum
Datenschutz
 
 
  SPOT ON
 

DPP-4 inhibitors - clinical benefit still unproven

 
  NEW ON THE MARKET

Lisdexamfetamine (ELVANSE) as second-line therapy for treatment-refractory attention deficit hyperactivity disorder?

 
  THERAPY FROM A CRITICAL VIEWPOINT

Vaccination against rotavirus for all infants?

 
  a-t READERS' QUESTIONS AND COMMENTS

Which contraceptive to use after venous thromboembolism?

Opioid substitution: is levomethadone (L-POLAMIDON) safer than methadone (e.g. METHADDICT)?

 
  IN BRIEF

Enough: 30 years of flunitrazepam (ROHYPNOL, generics)

 
  CURRENT ADR NETWORK REPORT
 

Angioedema with ALMASED powder

 
  SIDE EFFECTS
 

Progressive multifocal leukoencephalopathy (PML) with fingolimod (GILENYA) Promotion of quinine (LIMPTAR N) against leg cramps New warnings and contraindications for mefloquine

 
  e a-t IN INTERNET

Anaphylactic reactions with chlorhexidine (e.g. CHLORHEXAMED)

 

© arznei-telegramm 9/2013